x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

PharmaSource Podcast

Life Science Networks

Welcome to the PharmaSource podcast: the pharma and biotech podcast that explores the latest trends, challenges, and commercial opportunities shaping the biopharma manufacturing and outsourcing. In each episode we"ll be speaking with top executives, researchers, and outsourcing experts, who share their perspectives on topics such as building a smarter, more sustainable supply chain, how to partner with CDMOs, digital transformation, procurement and external manufacturing strategies, and plenty more

science life sciences

All Episodes

00:28:11

Six Strategic Imperatives for CDMO-Sponsor Success:...

PharmaSource Podcast ·

2025/06/17

Simon Kucher opened CDMO Live 2025 in Rotterdam by unveiling brand new research developed in partnership with PharmaSource.The comprehensive study, presented by Kaan-Fabian Kekec and Clarita Simon, mapped the evolving landscape of CDMO-sponsor partnerships based on insights from over 100 industry experts.Read more

en

00:36:03

Quality as Catalyst: How Risk Culture and...

PharmaSource Podcast ·

2025/06/15

CDMO Live 2025, a panel sponsored by Lifecore Biomedical brought together industry quality leaders to discuss how quality management can become a strategic enabler rather than a compliance burden. The panel featured Jackie Klecker (EVP Quality & Development Services, Lifecore Biomedical), Liesbeth Foesters (VP Head of External & Clinical Supply Quality, UCB), Stefan Bouckaert (Vice President External Supply Integration Quality, Johnson & Johnson), and Gwladys Mabonzo (Associate Director

en

00:29:28

Axplora Strategy Teardown: Investing in High-Growth...

PharmaSource Podcast ·

2025/06/11

“We invest to meet the needs of the customer. What’s driving these investments are really the customer partnerships that we’re building to make these happen,” explains Arul Ramadurai, Chief Commercial Officer at Axplora.Axplora, a global leader in API small molecule and ADC manufacturing, was formed through the merger of Farmabios, Novasep, and PharmaZell. With 2,400 employees across ten API manufacturing sites in Europe, India and the US, the company has recently accelerated its growth strategy

en

00:29:00

Digital Manufacturing Networks in the Real World

PharmaSource Podcast ·

2025/06/08

At CDMO Live 2025, a panel sponsored by Aizon explored how pharma companies are transforming external manufacturing operations through digital integration, with experts from sharing practical approaches to implementation.The Digital Divide: Big Pharma vs Mid-Size PlayersThe panellists painted a stark contrast in digital maturity across the pharmaceutical manufacturing landscape. Dave O'Gara, pharmaceutical business consultant at Aizon with over 30 years experience at Novartis, outlined the

en

00:08:46

Pharma Supply Chain Disruptions: Rx-360’s Ryan Kelly...

PharmaSource Podcast ·

2025/06/05

“Know your supply chain. Make sure you have it well mapped. The biggest thing that we’ve seen coming out of COVID was investments in technology – that’s what’s helping manufacturers respond to the unexpected.”Ryan Kelly, Senior Director of Supply Chain Security and Brand Protection at Rx-360, delivered this stark assessment of pharmaceutical supply chain management during a live podcast recording at CDMO Live 2025 in Rotterdam.Ryan brings extensive experience in pharmaceutical supply chain security

en

00:28:39

Inside CellProthera's Strategic SEQENS Partnership:...

PharmaSource Podcast ·

2025/06/02

"There are not that many European CDMOs with commercial expertise in cell therapy - who understand the regulatory requirements and production challenges when you have to manufacture large quantities on a regular basis. This is why we ended up with a very short list of two or three potential suppliers."CellProthera's recent announcement of its manufacturing partnership with SEQENS for Phase III trials marks a pivotal moment in the French biotech's journey from research lab to

en

00:09:36

Building Better CDMO Relationships: ten23 health’s...

PharmaSource Podcast ·

2025/05/29

“My ambition for being a CDMO is that there will always be technical challenges, but I want to be transparent about the challenge and provide options to a customer.”Hanns-Christian Mahler, CEO of ten23 health, brings 15 years of sponsor-side experience to his current role leading a sterile product CDMO focused on drug product development, manufacturing and testing. His unique perspective from both sides of the outsourcing relationship provides valuable insights into building successful

en

00:23:12

Pharma Sustainability Focus: Science-Based Targets...

PharmaSource Podcast ·

2025/05/25

Leaders from the Pharmaceutical Supply Chain Initiative (PSCI) and Manufacture 2030 outlined the mounting pressure on contract manufacturers to address sustainability at CDMO Live 2025, with major pharma companies now making emissions reduction a prerequisite for business relationships.The Climate-Healthcare ConnectionRob Williams, Senior Director of Sustainable Procurement at AstraZeneca and Chair of PSCI, opened with a stark reality check about healthcare's environmental impact. "Healthcare

en

00:10:02

How Sandoz Navigates Uncertainty with 400+ External...

PharmaSource Podcast ·

2025/05/22

“Nobody knows exactly what will happen, so making yourself anxious about unknowns doesn’t help. You must be prepared for multiple scenarios, ready and flexible to react quickly when changes do occur.”Maik Talarczyk, Director of PMO Office and Strategy in External Manufacturing Operations at Sandoz, brings extensive expertise in managing external manufacturing relationships and strategic operations for one of the world’s largest generic pharmaceutical companies, with over 20,000 employees

en

00:35:55

Pharma's New Manufacturing Playbook for Turbulent Times

PharmaSource Podcast ·

2025/05/18

CDMO Live 2025 Highlights: How Bayer, Boehringer Ingelheim, and Leo Pharma are rebuilding manufacturing strategiesComplexity Challenge: With thousands of SKUs to manage (Bayer handles 5,000+, half outsourced), companies struggle with aging portfolios and aggressive commercial expansion.Geopolitical Reshuffling: A staggering 62% of pharma companies are restructuring their manufacturing footprints in response to global tensions.Different Resilience Approaches:- Boehringer Ingelheim (family-owned)

en

00:29:16

Trump 2.0 and Drug Manufacturing: "Nobody Knows...

PharmaSource Podcast ·

2025/05/14

Gil Roth, president of the Pharma and Biopharma Outsourcing Association (PBOA), delivered a stark assessment of the uncertain regulatory and trade environment facing US drug manufacturers under Donald Trump's administration at CDMO Live 2025.In a presentation characterised by its unflinching candour, Roth outlined the key challenges confronting contract manufacturers, from rapidly changing tariff policies to mass layoffs at the FDA. His central message was bracingly simple: "Nobody knows

en

00:27:54

Building Resilience in Life Sciences with Beth...

PharmaSource Podcast ·

2025/05/12

“Over 90% of people you meet in life sciences are going to be dealing with failure every day. You have to normalize failure in this industry to get the success you want,” says Beth Benatti Kennedy, discussing the unique pressures facing pharmaceutical professionals.Beth Benatti Kennedy brings more than two decades of experience as a leadership and resilience executive coach, working with major pharmaceutical companies including Takeda, Nautilus Biotechnology, and Pfizer. Beth is also the author of

en

00:22:00

Beyond Auditing: How Qualifyze Proactively Manages...

PharmaSource Podcast ·

2025/05/07

“The pharmaceutical industry is very good at being reactive. If something happens, they have very clear processes, but they’re not so good anticipating change.”David Schneider, Founder & CEO of Qualifyze, brings more than a decade of experience working in investment banking (JP Morgan), Fortune 500 companies (BASF), and management consulting (McKinsey). He now leads Qualifyze, a company transforming supply risk management in the pharmaceutical industry.With operations across Frankfurt,

en

00:45:24

Valneva External Manufacturing: Balancing Risk-Taking...

PharmaSource Podcast ·

2025/04/27

“In Big Pharma, innovation is often stifled because the bureaucracy and mindset completely kills creativity and intuition needed for discovery. That’s why they now prefer to allocate their early-phase resources to smaller biotechs,” explains Julien Laizé, sharing candid insights about the delicate balance between innovation and compliance in vaccine manufacturingJulien Laizé serves as Director of External Manufacturing CTM at Valneva, a French-based specialty vaccine company developing and

en

00:19:19

How Almac’s Trust Ownership Enables CDMO Success -...

PharmaSource Podcast ·

2025/04/23

“We are privately owned by a Trust, which means all our profits are reinvested in the company. This translates to steady growth – maybe slower compared to other service providers, but we’re quite proud of that steady growth,” explains Franciane Chevot, Senior Business Development Manager at Almac.With 55 years of industry experience, approximately 7,500 employees, and 18 facilities worldwide across Europe, North America, and Asia, Almac has established a global footprint. However, it’s their

en

00:21:26

Private Equity and Digital Maturity in the CDMO...

PharmaSource Podcast ·

2025/04/21

“AI doesn’t have to be the first port of call. Many organisations still need to focus on the paper-to-glass journey before they can think about more advanced technologies” Vishnu Dwadasi, Director of Life Sciences at West Monroe, brings extensive experience across pharmaceutical operations, consulting and business development from both the sponsor and CDMO sides. His career path through companies including Catalent, BioDuro, PII and now West Monroe has given him unique insights into the evolving

en

00:19:01

BioDuro: Building Strategic Partnerships Through...

PharmaSource Podcast ·

2025/04/20

“Our goal is to be more than a service provider. We aim to be a strategic partner that grows with our clients from bench to bedside.” – Dr. Jim LiDr. Jim Li, President of CMC Solutions at BioDuro, brings extensive experience as a chemist and pharmaceutical industry veteran, having held leadership positions at global companies including Pfizer and Henkel before joining BioDuro to build up and manage the company’s CMC business.In the latest PharmaSource podcast episode, Jim explains how BioDuro’s

en

00:44:03

Animal Health Manufacturing: Boehringer Ingelheim’s...

PharmaSource Podcast ·

2025/04/17

“Managing hundreds of products across multiple species requires a different approach to network strategy than human pharma,” explains Bernhard Boehm, Head of External Manufacturing for Animal Health at Boehringer Ingelheim.Bernhard Boehm leads external manufacturing for animal health as VP of 3PM at Boehringer Ingelheim, bringing nearly 20 years of pharmaceutical experience across regulatory, quality, R&D, and site management roles before transitioning to animal health five years ago.Ahead of

en

00:25:50

The launch of a new CDMO: Meribel Pharma Solutions -...

PharmaSource Podcast ·

2025/04/15

Exclusive interview for PharmaSource ahead of CDMO Live“We’ve combined these two solid legacies into a new, agile CDMO with a unique focus on high-value small and medium-scale production,” says Bruce Vielle, CEO of the newly formed Meribel Pharma Solutions.Bruce Vielle, an experienced industrial business leader with extensive expertise in lean manufacturing and managing multi-site operations across automotive, aerospace, and pharmaceutical sectors, is spearheading the launch of Meribel Pharma

en

00:28:37

How Afton Scientific’s Quality-First Approach Fuels...

PharmaSource Podcast ·

2025/04/12

“Trust is what your customers need most. They take a great risk when they sign up with you to make their product. They need access within your organization to feel confident you’ll get things done the way they want.” Thomas Thorpe, CEO of Afton Scientific, brings 45 years of pharmaceutical operations experience to his founder-led Contract Development and Manufacturing Organisation (CDMO), which has grown from bootstrapped beginnings to a company with close to 100 employees specialising in sterile

en

179 results

Similar Podcasts

X Minus 1 - Old Time Radio Show

Inception Point Ai

Science, Spoken

WIRED

This Week in Space (Audio)

TWiT

DarshanTalks Podcast

Darshan Kulkarni

The Best of Coast to Coast AM

iHeartPodcasts and Coast to Coast AM